Company news
Novamind Inc news in 2021
Novamind Inc's news releases, calls and decks from 2021, newest first.
Novamind Signs Definitive Agreement to Acquire Arizona-based Clinics
December 23, 2021
Novamind Opens New Clinic with Specialized Focus on Substance Use Disorders
December 6, 2021
Novamind to Present at the H.C. Wainwright 2nd Annual Psychedelics Conference on December 6
December 2, 2021
Novamind Partners with Uruguay-Based Bienstar Wellness to Develop Latin America's First Integrative Mental Health Clinic Network
December 1, 2021
Novamind Reports Fiscal Q1 Financial Results and Operating Highlights
November 29, 2021
Novamind Unveils New Logo and Invests in Unified Brand
November 24, 2021
Novamind Signs LOI to Acquire Two Mental Health Clinics in Arizona
November 16, 2021
Novamind to Present at International Summit on Psychedelic Therapies for Mental Illness
November 15, 2021
Novamind Enters New Lease Agreement Responding to Patient Demand
November 12, 2021
Novamind Secures Insurance Coverage for Ketamine from Four Major Payors
November 10, 2021
Novamind Announces Revocation of Cease Trade Order and Reinstatement of Trading
November 8, 2021
CSE Bulletin: Reinstatement - Novamind Inc. (NM)
November 8, 2021
Novamind Reports FY2021 Financial Results and Operating Highlights
November 5, 2021
CSE Bulletin: Suspensions (MMI, CNFA, VPN, NM, EXM)
November 4, 2021
Novamind Announces Cease Trade Order and Delay in Filing Annual Financial Statements
November 4, 2021
Novamind Unveils Stealth Mode Investment in Alto Neuroscience
October 22, 2021
Novamind Granted DEA Licenses for Psilocybin Research
October 13, 2021
Novamind to Present at LD Micro and KCSA Conferences
October 8, 2021
Novamind Launches New Psychedelic Palliative Care Program
October 7, 2021
Novamind to Deliver Keynote at PSYCH Investor Summit on October 7, 2021
October 4, 2021
Novamind Opens 6th Integrative Psychiatry Clinic, Adds 3rd Clinical Research Site
September 30, 2021
Novamind to Present at Benzinga Healthcare Conference
September 29, 2021
Novamind Announces DTC Eligibility for its Common Shares
September 24, 2021
Novamind to Present at Benzinga Healthcare Conference
September 23, 2021
Novamind Announces Inclusion in NYSE Listed AdvisorShares Psychedelics ETF
September 20, 2021
Novamind to Present at Life Sciences Investor Forum
September 14, 2021
Novamind to Serve as Research Site for Karuna Therapeutics Late-Stage Clinical Trial
September 13, 2021
Novamind Uplists to OTCQB Venture Market
September 9, 2021
Novamind to Present at H.C. Wainwright 23rd Annual Global Investment Conference
September 8, 2021
Novamind Divests Non-Core Retreat Investment
August 11, 2021
Novamind Strengthens Mental Health Expertise, Adds Communications Leader
August 6, 2021
Novamind Opens 5th Clinic Location Specialized in Integrative Psychiatry for Patients with Treatment-Resistant Conditions
July 29, 2021
Novamind Has Applied to Have its Common Shares Posted for Trading on the OTCQB in the United States
July 21, 2021
Novamind Selected as Research Site for Bionomics' PTSD Clinical Trial
July 8, 2021
Novamind Launches Psychedelic Therapy Frontiers Podcast
June 30, 2021
Novamind Welcomes Dr. Paul Thielking as Chief Scientific Officer
June 23, 2021
Novamind Announces US$1,000,000 Strategic Investment in Stealth Mode Drug Development Company
June 17, 2021
Novamind to Present at the H.C. Wainwright Psychedelics Conference on June 17, 2021
June 15, 2021
Novamind Launches Psychedelic Therapy Protocol for Frontline Healthcare Workers
June 10, 2021
Novamind Reports Fiscal Q3 Financial Results and Operating Highlights
June 1, 2021
Novamind Opens Client Care Center to Support High Demand for Treatments
May 18, 2021
Novamind Doubles in Size, Adds Four New Psychedelic Mental Health Clinics
May 4, 2021
Novamind Collaborates with Center for Change
April 21, 2021
Novamind Announces Participation at the Planet MicroCap Showcase on April 20 - 22, 2021
April 20, 2021
Novamind to Present at the Planet MicroCap Virtual Event on April 22, 2021
April 19, 2021
Novamind Increases Strategic Investment in Bionomics
April 13, 2021
Novamind to Present at Benzinga Biotech Conference
March 24, 2021
Novamind to Present at Benzinga Biotech Conference
March 22, 2021
Novamind Partners with Merck for New Treatment-Resistant Depression Trial
March 18, 2021
Novamind Expands Leadership Team, Accelerating M&A
March 3, 2021
Decks in 2021
- Investor Presentation (November 2021)
Investor deck · 23 slides · Nov 29, 2021